The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Boissel Stephane since 2019.
The trader's CIK number is 1755198.
At the time of the last reporting, Boissel Stephane was the EVP, Corp. Strat. & Int. CFO of Sangamo Therapeutics, Inc. (stock ticker symbol SGMO).
Also see all insider trading activities at Sangamo Therapeutics, Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2020 | SGMO | 0 | $0 | 0 | $0 | 14,907 | $0 |
| 2019 | SGMO | 0 | $0 | 0 | $0 | 11,137 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-06-04 | SGMO | Option Ex | 14,907 | .00 | 0 |
| 2019-08-12 | SGMO | Option Ex | 11,137 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Boissel Stephane (EVP, Corp. Strat. & Int. CFO of Sangamo Therapeutics, Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.